NCT05178524View on ClinicalTrials.gov

Clinical Study on BIFICO Accelerating Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

May 30, 2022

Study Completion Date

June 30, 2022

Conditions
Gut MicrobiotaHepatocellular CarcinomaBifidobacterium
Interventions
DRUG

BIFICO

Live combined Bifidobacterium, Lactobacillus and Enterococcus Capsules

Trial Locations (1)

430030

The hepatic surgery of Tongji hospital, Wuhan

All Listed Sponsors
lead

Tongji Hospital

OTHER